{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T02:58:51Z","timestamp":1779159531230,"version":"3.51.4"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":386,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.ajpath.2012.03.023","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T05:01:31Z","timestamp":1337749291000},"page":"151-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Type 1 Interferons Suppress Accelerated Osteoclastogenesis and Prevent Loss of Bone Mass During Systemic Inflammatory Responses to Pneumocystis Lung Infection"],"prefix":"10.1016","volume":"181","author":[{"given":"Michelle","family":"Wilkison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Gauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchao","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Searles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2012.03.023_bib1","first-page":"10","article-title":"Interferon-producing plasmacytoid dendritic cells and the pathogenesis of AIDS","volume":"8","author":"Siegal","year":"2003","journal-title":"Res Initiat Treat Action"},{"key":"10.1016\/j.ajpath.2012.03.023_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1471-4906(01)01925-1","article-title":"The importance of the innate immune system in controlling HIV infection and disease","volume":"22","author":"Levy","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib3","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajpath.2012.03.023_bib4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1568-9972(02)00086-1","article-title":"HIV and autoimmunity","volume":"1","author":"Zandman-Goddard","year":"2002","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ajpath.2012.03.023_bib5","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1089\/088922200750005994","article-title":"Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy","volume":"16","author":"Isgro","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.ajpath.2012.03.023_bib6","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood.V91.5.1479","article-title":"The influence of human immunodeficiency virus-1 on hematopoiesis","volume":"91","author":"Moses","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2012.03.023_bib7","doi-asserted-by":"crossref","first-page":"e1000239","DOI":"10.1371\/journal.pmed.1000239","article-title":"Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy\u2013the CASCADE collaboration: a collaboration of 23 cohort studies","volume":"7","author":"Wolbers","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajpath.2012.03.023_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/135965350701200602","article-title":"CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy","volume":"12","author":"Wolbers","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ajpath.2012.03.023_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0952-7915(02)00011-0","article-title":"Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity","volume":"15","author":"Levy","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.immuni.2006.08.014","article-title":"Complex modulation of cell type-specific signaling in response to type I interferons","volume":"25","author":"van Boxel-Dezaire","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2012.03.023_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1521-6616(03)00178-5","article-title":"Protection from HIV\/AIDS: the importance of innate immunity","volume":"108","author":"Levy","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib12","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood.V98.4.906","article-title":"Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients","volume":"98","author":"Soumelis","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2012.03.023_bib13","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1189\/jlb.0306154","article-title":"Type I interferon production in HIV-infected patients","volume":"80","author":"Hosmalin","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib14","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.4049\/jimmunol.1002000","article-title":"CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis HIV, type I IFN, and IL-7","volume":"186","author":"Catalfamo","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib15","doi-asserted-by":"crossref","first-page":"e2961","DOI":"10.1371\/journal.pone.0002961","article-title":"HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation","volume":"3","author":"Boasso","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2012.03.023_bib16","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.4049\/jimmunol.168.9.4796","article-title":"Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals","volume":"168","author":"Chehimi","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib17","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1182\/blood-2010-12-322453","article-title":"Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection","volume":"117","author":"Corbeau","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2012.03.023_bib18","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/00002030-200109070-00002","article-title":"Interferon-alpha generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infection","volume":"15","author":"Siegal","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.ajpath.2012.03.023_bib19","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1378\/chest.08-0364","article-title":"Changing global epidemiology of pulmonary manifestations of HIV\/AIDS","volume":"134","author":"Hull","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ajpath.2012.03.023_bib20","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/01.aids.0000226949.64600.f9","article-title":"The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy","volume":"20","author":"Grubb","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.ajpath.2012.03.023_bib21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/COH.0b013e3281a3c092","article-title":"Osteopenia and osteoporosis in HIV: pathogenesis and treatment","volume":"2","author":"Chew","year":"2007","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.ajpath.2012.03.023_bib22","first-page":"359242","article-title":"Osteoimmunopathology in HIV\/AIDS: a translational evidence-based perspective","volume":"2011","author":"Barkhordarian","year":"2011","journal-title":"Patholog Res Int"},{"key":"10.1016\/j.ajpath.2012.03.023_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/156652406777435435","article-title":"Bone diseases associated with human immunodeficiency virus infection: pathogenesis, risk factors and clinical management","volume":"6","author":"Bongiovanni","year":"2006","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.ajpath.2012.03.023_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev.immunol.24.021605.090646","article-title":"Osteoimmunology: interplay between the immune system and bone metabolism","volume":"24","author":"Walsh","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrrheum.2009.217","article-title":"Osteoimmunology and the effects of the immune system on bone","volume":"5","author":"Takayanagi","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nri1779","article-title":"Bone-marrow haematopoietic-stem-cell niches","volume":"6","author":"Wilson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ni1331","article-title":"The hematopoietic stem cell in its place","volume":"7","author":"Adams","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib28","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI28568","article-title":"The stem cell niches in bone","volume":"116","author":"Yin","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2012.03.023_bib29","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1301\/nr.2007.dec.S147-S151","article-title":"Osteoporosis and inflammation","volume":"65","author":"Mundy","year":"2007","journal-title":"Nutr Rev"},{"key":"10.1016\/j.ajpath.2012.03.023_bib30","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/MED.0b013e328340533d","article-title":"Skeletal manifestations of systemic autoimmune diseases","volume":"17","author":"Kamen","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.ajpath.2012.03.023_bib31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1753465811400490","article-title":"COPD: a multifactorial systemic disease","volume":"5","author":"Huertas","year":"2011","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.ajpath.2012.03.023_bib32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1183\/09031936.06.00120604","article-title":"Circulating haemopoietic and endothelial progenitor cells are decreased in COPD","volume":"27","author":"Palange","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ajpath.2012.03.023_bib33","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.ajpath.2012.03.023_bib34","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/jmv.20938","article-title":"RANKL\/OPG\/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men","volume":"79","author":"Gibellini","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/QAI.0b013e31821ecf4c","article-title":"Low CD4 count is associated with an increased risk of fragility fracture in HIV-infected patients","volume":"57","author":"Yong","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajpath.2012.03.023_bib36","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s10620-006-9250-x","article-title":"Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases","volume":"52","author":"Kaur","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ajpath.2012.03.023_bib37","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1023\/B:DDAS.0000042246.58984.98","article-title":"Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease","volume":"49","author":"Kaur","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ajpath.2012.03.023_bib38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/art.24283","article-title":"Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients","volume":"61","author":"Komano","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2012.03.023_bib39","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1128\/JCM.01712-09","article-title":"Airway obstruction is increased in pneumocystis-colonized human immunodeficiency virus-infected outpatients","volume":"47","author":"Morris","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib40","doi-asserted-by":"crossref","unstructured":"Flammer JR, Dobrovolna J, Kennedy MA, Chinenov Y, Glass CK, Ivashkiv LB, Rogatsky I. The type I interferon signaling pathway is a target for glucocorticoid inhibition. Mol Cell Biol 30:4564\u20134574","DOI":"10.1128\/MCB.00146-10"},{"key":"10.1016\/j.ajpath.2012.03.023_bib41","doi-asserted-by":"crossref","first-page":"9554","DOI":"10.1073\/pnas.1017296108","article-title":"Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation","volume":"108","author":"Bhattacharyya","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2012.03.023_bib42","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.4049\/jimmunol.178.10.6604","article-title":"Type I interferon signaling and B cells maintain hemopoiesis during Pneumocystis infection of the lung","volume":"178","author":"Meissner","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib43","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.4049\/jimmunol.1003558","article-title":"Prevention of bone marrow cell apoptosis and regulation of hematopoiesis by type I IFNs during systemic responses to pneumocystis lung infection","volume":"186","author":"Taylor","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1359\/jbmr.080812","article-title":"Bisphosphonate therapy ameliorates hearing loss in mice lacking osteoprotegerin","volume":"24","author":"Kanzaki","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajpath.2012.03.023_bib45","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1084\/jem.172.3.937","article-title":"Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice","volume":"172","author":"Harmsen","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2012.03.023_bib46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1939-165X.2004.tb00351.x","article-title":"Cytologic evaluation of bone marrow in rats: indications, methods, and normal morphology","volume":"33","author":"Bolliger","year":"2004","journal-title":"Vet Clin Pathol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib47","doi-asserted-by":"crossref","first-page":"14221","DOI":"10.1074\/jbc.M111551200","article-title":"8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway","volume":"277","author":"Tintut","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2012.03.023_bib48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2012.03.023_bib49","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF02556360","article-title":"Bone histomorphometry: proposed system for standardization of nomenclature, symbols, and units","volume":"42","author":"Parfitt","year":"1988","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ajpath.2012.03.023_bib50","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units: report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajpath.2012.03.023_bib51","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bone.2005.07.028","article-title":"The use of micro-CT to evaluate cortical bone geometry and strength in nude rats: correlation with mechanical testing, pQCT and DXA","volume":"38","author":"Bagi","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.ajpath.2012.03.023_bib52","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1182\/blood-2004-06-2480","article-title":"Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche","volume":"105","author":"Taichman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2012.03.023_bib53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.immunol.25.022106.141631","article-title":"The multiple roles of osteoclasts in host defense: bone remodeling and hematopoietic stem cell mobilization","volume":"25","author":"Kollet","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib54","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.192.4.463","article-title":"Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis","volume":"192","author":"Min","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2012.03.023_bib55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MOH.0b013e3282f15fa6","article-title":"Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis","volume":"15","author":"Secchiero","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib56","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/08916930701693180","article-title":"Osteoclasts: the innate immune cells of the bone","volume":"41","author":"Wu","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ajpath.2012.03.023_bib57","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nature01660","article-title":"Control of osteoblast function and regulation of bone mass","volume":"423","author":"Harada","year":"2003","journal-title":"Nature"},{"issue":"Suppl 3","key":"10.1016\/j.ajpath.2012.03.023_bib58","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1186\/ar581","article-title":"Signaling crosstalk between RANKL and interferons in osteoclast differentiation","volume":"4","author":"Takayanagi","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.ajpath.2012.03.023_bib59","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1164\/rccm.200401-094OC","article-title":"Association of chronic obstructive pulmonary disease severity and pneumocystis colonization","volume":"170","author":"Morris","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajpath.2012.03.023_bib60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/15412550701817656","article-title":"Pneumocystis: a novel pathogen in chronic obstructive pulmonary disease","volume":"5","author":"Morris","year":"2008","journal-title":"COPD"},{"key":"10.1016\/j.ajpath.2012.03.023_bib61","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.autrev.2005.04.014","article-title":"Immunodysregulation of HIV disease at bone marrow level","volume":"4","author":"Isgro","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ajpath.2012.03.023_bib62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/aid.2005.21.51","article-title":"HIV type 1 protease inhibitors enhance bone marrow progenitor cell activity in normal subjects and in HIV type 1-infected patients","volume":"21","author":"Isgro","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2012.03.023_bib63","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01621881","article-title":"Macrophage colon-stimulating factor (M-CSF) is essential for differentiation rather than proliferation of osteoclast progenitors","volume":"3","author":"Suda","year":"1993","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ajpath.2012.03.023_bib64","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.0105-2896.2005.00327.x","article-title":"Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system","volume":"208","author":"Tanaka","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ajpath.2012.03.023_bib65","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.4049\/jimmunol.178.11.6705","article-title":"Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production","volume":"178","author":"Chang","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib66","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1084\/jem.20051725","article-title":"Twist mediates suppression of inflammation by type I IFNs and Axl","volume":"203","author":"Sharif","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2012.03.023_bib67","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.immuni.2011.02.006","article-title":"Type I interferon inhibits interleukin-1 production and inflammasome activation","volume":"34","author":"Guarda","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2012.03.023_bib68","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/416744a","article-title":"RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta","volume":"416","author":"Takayanagi","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.03.023_bib69","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.4049\/jimmunol.175.2.1232","article-title":"Elimination of senescent neutrophils by TNF-related apoptosis-inducing [corrected] ligand","volume":"175","author":"Lum","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2012.03.023_bib70","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.leukres.2005.09.015","article-title":"A probable role for trail-induced apoptosis in the pathogenesis of marrow failure","volume":"30","author":"Kakagianni","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.ajpath.2012.03.023_bib71","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02040","article-title":"Osteoblastic cells regulate the haematopoietic stem cell niche","volume":"425","author":"Calvi","year":"2003","journal-title":"Nature"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944012003124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944012003124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:08:07Z","timestamp":1722298087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944012003124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0002944012003124"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.03.023","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 Interferons Suppress Accelerated Osteoclastogenesis and Prevent Loss of Bone Mass During Systemic Inflammatory Responses to Pneumocystis Lung Infection","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}